Guided by former Notified Body assessors and product experts
who understand both device innovation and conformity assessments.
Many regulatory delays are not caused by lack of effort, but by lack of strategic alignment early in the journey.
Leadership teams often face critical regulatory decisions while balancing development, funding, clinical evidence, and commercial timelines.
MedStride serves to bring structure, clarity and strategic guidance to those high-stakes moments.
MedStride was founded by Dr Benyamin Rahmani to help MedTech companies navigate regulatory complexity with greater clarity, structure, and commercial alignment.
His experience spans Notified Body assessment and hands-on MedTech engineering, providing a practical understanding of how regulatory decisions influence timelines, evidence strategy, funding, and market access.
Today, he works closely with founders and leadership teams developing high-risk and innovative medical devices under MDR.
We believe regulatory strategy should support commercial progress, not slow it down. Our approach combines:
Regulatory insight
Commercial awareness
Structured execution
Practical decision-making
The goal is to help MedTech teams bring innovative technologies to patients faster while reducing compliance risk and unnecessary delays.
Notified Body Perspective
Understanding how submissions are assessed, where delays occur, and what strong evidence looks like in practice.

MedTech Innovation Experience
Hands-on involvement supporting innovative and high-risk medical technologies through critical stages of development and approval.

Strategic Leadership Support
Working directly with founders and leadership teams navigating investor pressure, technical complexity, and regulatory uncertainty.

Clarity in evolving regulatory situations
Insight shaped by Notified Body experience
Strategic alignment between regulatory and commercial objectives
Flexible senior-level support without unnecessary overhead
Practical guidance tailored to high-risk and innovative devices
“We had momentum, but no direction.
Now we do.”
MedTech Founder (Surgical Instruments)
Whether you are preparing for approval, facing delays, or scaling internationally, we can help define the right path forward.